Analytical Data
-
Gene name
C11orf57
- Application
-
Alternative Names
C11orf57; chromosome 11 open reading frame 57; CK057_HUMAN; FLJ10726; hypothetical Protein LOC55216; Uncharacterized Protein C11orf57
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6ZUT1
-
Expression Region
1-263aa
-
AA Sequence
MWKIRELEKQMEDAYRGTKRKMLPSSSSRMRSDGFDEESQRYYWRPKNEISGTLEDDFLKAKSWNKKFYDYEANMPDRWGHSGYKELYPEEFETDSDQQDITNGKKTSPQVKSSTHESRKHKKSKKSHKKKQKKRSHKKQKKSKKEATDITADSSSEFSEETGASGTRKGKQPHKRKKKSRKKSLKKPALFLEAESNTSHSDDSASSSSEESEERDTKKTKRKKREKKAHTSVANNEIQERTNKRTNWKVATDERSAESSEDD
-
Molecular Weight
57.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C11orf57, also known as Chromosome 11 Open Reading Frame 57, is a relatively uncharacterized protein that has garnered attention in recent years for its potential roles in cellular processes and its implications in various diseases. Research has indicated that C11orf57 may be involved in fundamental biological functions, including cell proliferation, apoptosis, and immune response regulation. Initial studies suggest that dysregulation of C11orf57 expression can be associated with certain cancers and autoimmune disorders, prompting scientists to investigate its mechanistic pathways. The recombinant expression of C11orf57 allows for detailed analysis of its structure-function relationships, enabling researchers to explore its interactions with other proteins and its role in cellular signaling networks. Moreover, understanding C11orf57 could provide insights into novel therapeutic targets for the treatment of diseases linked to its dysregulation. As such, recombinant C11orf57 is being studied in various model systems to elucidate its biological significance and potential applications in medicine. The ongoing research efforts aim to clarify the functional roles of this protein, which may ultimately contribute to advancements in diagnostics and therapeutics for conditions such as cancer and inflammatory diseases.
